Management of diabetes type 1 with hybrid closed-loop

Introduction: Type 1 diabetes mellitus (T1DM), in which the pancreas is no longer able to produce insulin to naturally control blood sugar, can be a major problem for the patient in terms of disease management. Closed-loop hybrid systems are designed to automate insulin delivery to improve T1DM outcomes and reduce the burden and distress for the user. The hybrid closed-loop makes an important contribution to reducing the difficulties of disease, also its control and management.Research goal: The goal is to examine how the closed hybrid loop system has contributed to the management of T1DM and improved the quality of life of patients.Participants and Methods: The survey was based on a non-experimental quantitative method with a questionnaire developed for the study. The surveys were distributed on Facebook in groups dedicated to patients with T1DM. The survey covered hybrid closed-loop users in Slovenia. Descriptive and inferential statistics were used for the statistical processing of the obtained data. IBM SPSS Statistics (version 20) was used.Results: The hybrid closed-loop system provides respondents with better management of T1DM and a better quality of life. 82.9% of respondents have fewer hypoglycaemic episodes than before using the hybrid system, 65.7% of respondents detect signs of hypoglycaemia earlier and fear of hypoglycaemia is reduced. 70.3% of respondents say they have less worries about diabetes.Conclusion: The study confirmed the prediction that respondents with T1DM are satisfied with the hybrid closed-loop system and notice fewer fluctuations in their blood sugar. The latest treatment method also helps to improve the quality of life. Because of its benefits, respondents recommend using a hybrid closed-loop system.